Xiaoyu Ma

Xiaoyu Ma

Auto-generated profile, based on publicly available information

Xiaoyu Ma

Beijing Key Laboratory of Genetic Engineering Drug and Biotechnology, College of Life Sciences, Beijing Normal University , Beijing 100875, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2022 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
LCLi Chenxi
Li Chenxi
XMXiaoyu Ma
Xiaoyu Ma
LMLan Ma
Lan Ma
SZSihui Zhen
Sihui Zhen
YNYinan Na
Yinan Na
XZXudong Zhu
Xudong Zhu
The yeast SKI (superkiller) complex was originally identified from cells that were infected by the M ‘killer’ virus. Ski2, as the core of the SKI complex, is a cytoplasmic cofactor and regulator of RNA-degrading exosome. The putative RNA helicase Ski2 was highly conserved from yeast to animals and has been demonstrated to play a key role in the regulation of RNA surveillance, temperature sensitivity, and growth in several yeasts but not yet in Cryptococcus neoformans (C. neoformans). Here, we report the identification of a gene encoding an equivalent Ski2 protein, named SKI2, in the fungal pathogen C. neoformans. To obtain insights into the function of Ski2, we created a mutant strain, ski2Δ, with the CRISPR–Cas9 editing tool. Disruption of SKI2 impaired cell wall integrity. Further investigations revealed the defects of the ski2Δ mutant in resistance to osmotic stresses and extreme growth temperatures. However, significantly, the ability to undergo invasive growth under nutrient-depleted conditions was increased in the ski2Δ mutant. More importantly, our results showed that the ski2Δ mutant exhibited slightly lower virulence and severe susceptibility to anti-ribosomal drugs by comparison to the wild type, but it developed multidrug resistance to azoles and flucytosine. By constructing the double deletion strain ski2Δafr1Δ, we verified that increased Afr1 in ski2Δ contributed to the azole resistance, which might be influenced by nonclassical small interfering RNA. Our work suggests that Ski2 plays critical roles in drug resistance and regulation of gene transcription in the yeast pathogen C. neoformans.

10 December 2022 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
XMXiaoyu Ma
Xiaoyu Ma
LCLi Chenxi
Li Chenxi
LMLan Ma
Lan Ma
XZXuan Zhao
Xuan Zhao
YLYanjie Liu
Yanjie Liu
XZXudong Zhu
Xudong Zhu
The RNAi machinery has been extensively studied in plant and animal cells for their crucial roles in regulation of genome function. However, the potential roles of RNAi in controlling fungal growth and development have been poorly studied, especially in the basidiomycetous yeast Cryptococcus deneoformans. To characterize the biological functions of RNAi in the pathogenic fungus, comparative analysis of mRNA profiles using the high-throughput sequencing technology was performed for the wild type and the RNAi mutants of C. deneoformans. The results revealed a clear difference in the expression of genes associated with metabolic processes in the RNAi mutants. Besides, the growth under nutrient-limited conditions was significantly reduced in the ago2Δ mutant, suggesting the essential roles of Ago2 in nutrient metabolism. Further investigations revealed the differentially expressed transporters in the RNAi mutants, in which transporters involved in fluconazole efflux were significantly up-regulated. More importantly, on account of the upregulated transporters, RNAi mutant strains developed resistance to fluconazole. By disrupting AFR1 gene using the ‘suicide’ CRISPR-Cas9 system, we verified that the upregulated ABC transporter Afr1 in the RNAi mutants contributed to the fluconazole resistance. In summary, our data demonstrate that in C. deneoformans the RNAi pathway participates in nutrient metabolism and plays a role in the repression of fluconazole resistance, which provides a deep insight into RNAi mechanisms in Cryptococcus and brings great hints for clinical treatment of cryptococcosis. ● Transcriptome sequencing reveals biological functions of RNAi in C. deneoformans. ● Nutritional metabolism is deficient due to the AGO2 disruption. ● RNAi mechanism inhibits fluconazole resistance by regulating the expression of transporters.

17 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZSZhenghao Shen
Zhenghao Shen
ZDZeyu Duan
Zeyu Duan
XMXiaoyu Ma
Xiaoyu Ma
LSLinhao Song
Linhao Song
XLXin Luo
Xin Luo
LWLinqi Wang
Linqi Wang
Mycoviruses are prevalent across major fungal lineages, yet none have been reported in the Cryptococcus gattii species complex (CGSC), the causative agent of the largest known fungal outbreak in immunocompetent hosts. Consequently, the occurrence of mycoviruses and the host determinants governing their infection in this important pathogenic clade remain unexplored. Through screening of 386 Cryptococcus isolates, we identified a mycovirus, designated CgTV1, in an environmental isolate of the CGSC. CgTV1 is a double-stranded RNA (dsRNA) mycovirus of the genus Totivirus , with a genome encoding a capsid protein and an RNA-dependent RNA polymerase. We showed that CgTV1 establishes a cryptic infection, because neither viral presence nor its clearance significantly alters host transcriptomic profiles, suggesting the existence of mechanisms that maintain virus–host homeostasis. Population genomic analyses reveal that an intact RNAi pathway constitutes a critical genetic barrier, and CgTV1 persistence strictly requires loss-of-function mutations in both AGO1 and AGO2 . By pan-transcriptomics across 43 CGSC strains, we further uncovered an RNase III gene, CAI1 , which exhibits high expression in the mycovirus-positive isolate. Biochemical analysis indicates that Cai1 directly recognizes and degrades CgTV1 dsRNA, thereby constraining excessive mycoviral proliferation. We further demonstrate that Dicer and Cai1 act in parallel to maintain virus–host homeostasis: their combined ablation results in higher viral loads and more pronounced changes in host gene expression than ablation of either factor alone. Collectively, our findings provide the evidence of the occurrence of a mycovirus in the CGSC and reveal parallel mechanisms that enable cryptic mycoviral infections.